GENETIC ANALYSES OF GENES IN PRESENILIN RELATED PATHWAYS

早老素相关通路基因的遗传分析

基本信息

  • 批准号:
    7483171
  • 负责人:
  • 金额:
    $ 47.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-01 至 2008-08-31
  • 项目状态:
    已结题

项目摘要

In Project 2, we have shifted our focus to genetic analyses of positional candidate genes encoding proteins implicated in presenilin-related pathways. Over the past decade, our group has led the ascertainment, evaluation, and comprehensive genetic analyses of the NIMH Genetics Initiative Alzheimer's disease (AD) sample. This set of AD families, which currently includes 1527 individuals in 457 families, is the largest uniformly ascertained and evaluated sample ever assembled for the study of AD genetics. In separately funded studies, our laboratory recently completed the genetic analyses and preliminary follow-up studies of a comprehensive high-resolution genome screen for novel AD genes. The genome screen revealed that in addition to the expected highly significant linkage peak on chromosome 19q (APOE locus), several regions demonstrate evidence of 'suggestive' linkage to AD. In separately funded studies, we are further refining these linkage regions using additional markers. The immense data emanating from this screen constitute a powerful resource for research efforts aimed at identifying novel AD genes. To identify novel AD genes, we propose a positional candidate approach in which we test biologically compelling candidate genes from our AD genetic linkage peaks using family-based association, augmented by linkage disequilibrium mapping. Clusters of tightly spaced single nucleotide polymorphisms (SNPs) in positional candidate genes encoding proteins that are biologically implicated in presenilin-related pathways will be tested for association with AD. These genes have been divided into six categories: a. presenilin interactors, b. PS/gamma-secretase substrates, c. PS/gamma-secretase complex components and proteins that affect PS/gamma-secretase activity/Abeta generation, d. amyloid precursor protein (APP) C-terminus/APP intracellular domain (AICD) interactors, e. AICD transcriptional targets, and f. presenilin-like signal peptide peptidases. Testing of these genes will be prioritized according to their genomic position relative to the best-confirmed AD genetic linkage peaks, and their biological relevance to AD pathogenesis. Candidate genes for which positive signals are successfully found in the NIMH sample will be tested in an independent sample, the Consortium on Alzheimer's Genetics (CAG) sample. SNPs found to be strongly associated with AD in these samples will be phenotypically and functionally characterized including collaborative analyses with the six other PPG laboratories.
在项目2中,我们已经将我们的重点转移到位置候选基因编码蛋白质的遗传分析,涉及早老相关途径。在过去的十年中,我们的团队领导了NIMH遗传学倡议阿尔茨海默病(AD)样本的确定,评估和全面的遗传分析。这组AD家族,目前包括457个家族中的1527个个体,是有史以来为AD遗传学研究而收集的最大的统一确定和评估样本。在独立资助的研究中,我们的实验室最近完成了一项遗传分析和初步随访研究, 全面的高分辨率基因组筛选新的AD基因。基因组筛选显示,除了染色体19 q(APOE基因座)上预期的高度显著的连锁峰外,还有几个区域显示出与AD“暗示性”连锁的证据。在单独资助的研究中,我们正在使用其他标记进一步完善这些连锁区域。从这个屏幕发出的巨大数据构成了一个强大的资源,旨在确定新的AD基因的研究工作。为了识别新的AD基因,我们提出了一个定位的基因。 候选人的方法,其中我们测试生物学上令人信服的候选基因,从我们的AD遗传连锁峰使用基于家庭的关联,增加了连锁不平衡映射。将检测编码与早老蛋白相关通路有生物学关联的蛋白质的位置候选基因中紧密间隔的单核苷酸多态性(SNP)簇与AD的相关性。这些基因被分为六类:a.早老素相互作用物,B. PS/γ-分泌酶底物,c. PS/γ-分泌酶复合物组分和影响PS/γ-分泌酶活性/Abeta产生的蛋白质,d.淀粉样前体蛋白(APP)C末端/APP胞内结构域(AICD)相互作用物,e. AICD转录靶标,和f.早老素样信号肽肽酶。这些基因的检测将根据其相对于最佳确认的AD遗传连锁峰的基因组位置及其与AD发病机制的生物学相关性进行优先排序。在NIMH样本中成功发现阳性信号的候选基因将在独立的 样本,阿尔茨海默氏症遗传学联盟(CAG)样本。在这些样本中发现与AD密切相关的SNP将进行表型和功能表征,包括与其他六个PPG实验室的合作分析。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RUDOLPH Emile TANZI其他文献

RUDOLPH Emile TANZI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RUDOLPH Emile TANZI', 18)}}的其他基金

Characterization of Alzheimer's Mutations in ADAM10.
ADAM10 中阿尔茨海默病突变的表征。
  • 批准号:
    8890722
  • 财政年份:
    2012
  • 资助金额:
    $ 47.11万
  • 项目类别:
Characterization of Alzheimer's Mutations in ADAM10.
ADAM10 中阿尔茨海默病突变的表征。
  • 批准号:
    8438141
  • 财政年份:
    2012
  • 资助金额:
    $ 47.11万
  • 项目类别:
Characterization of Alzheimer's Mutations in ADAM10.
ADAM10 中阿尔茨海默病突变的表征。
  • 批准号:
    8550747
  • 财政年份:
    2012
  • 资助金额:
    $ 47.11万
  • 项目类别:
Characterization of Alzheimer's Mutations in ADAM10.
ADAM10 中阿尔茨海默病突变的表征。
  • 批准号:
    8721305
  • 财政年份:
    2012
  • 资助金额:
    $ 47.11万
  • 项目类别:
Alzheimer's Disease Genes, Cellular Pathways and Therapies
阿尔茨海默病基因、细胞通路和治疗
  • 批准号:
    7001149
  • 财政年份:
    2005
  • 资助金额:
    $ 47.11万
  • 项目类别:
ACAT inhibitors regulate palmitoylated APP and Abeta production
ACAT 抑制剂调节棕榈酰化 APP 和 Abeta 的产生
  • 批准号:
    9058612
  • 财政年份:
    2002
  • 资助金额:
    $ 47.11万
  • 项目类别:
Role of MAMs in stabilization and BACE1-mediated processing of palAPP.
MAM 在 palAPP 稳定和 BACE1 介导的加工中的作用。
  • 批准号:
    10451563
  • 财政年份:
    2002
  • 资助金额:
    $ 47.11万
  • 项目类别:
Role of MAMs in stabilization and BACE1-mediated processing of palAPP.
MAM 在 palAPP 稳定和 BACE1 介导的加工中的作用。
  • 批准号:
    9920896
  • 财政年份:
    2002
  • 资助金额:
    $ 47.11万
  • 项目类别:
ACAT inhibitors regulate palmitoylated APP and Abeta production
ACAT 抑制剂调节棕榈酰化 APP 和 Abeta 的产生
  • 批准号:
    8631103
  • 财政年份:
    2002
  • 资助金额:
    $ 47.11万
  • 项目类别:
Role of MAMs in stabilization and BACE1-mediated processing of palAPP.
MAM 在 palAPP 稳定和 BACE1 介导的加工中的作用。
  • 批准号:
    10210441
  • 财政年份:
    2002
  • 资助金额:
    $ 47.11万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 47.11万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 47.11万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 47.11万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 47.11万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 47.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 47.11万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 47.11万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 47.11万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 47.11万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 47.11万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了